TransMedics Group Inc. TMDX
$75.34
▼ -0.92% 24H
About
TransMedics Group Inc. is a commercial-stage medical technology company focused on advancing organ transplant therapy for patients with end-stage organ failure. It develops and commercializes the Organ Care System (OCS), a portable platform that preserves, optimizes, and monitors donor organs in near-physiologic condit…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees898
TickerTMDX
Statistics
Market Cap$2.60B
Revenue (TTM)$605.5M
Net Income$190.3M
Net Margin31.4%
EPS$4.87
P/E16.84
P/S4.00
P/B5.33
EV/EBITDA23.50
ROE45.2%
Dividend Yield—
Price$75.34
Data: Twelve Data · Revenue = mcap / P/S